China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
16.71
0.00 (0.00%)
Jun 9, 2026, 3:00 PM CST
SHA:600062 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, SHA:600062 stock has a consensus rating of "Strong Buy" and an average price target of ¥25.33. The average 1-year stock price forecast is 51.59% higher than the current stock price, while the lowest is ¥25.00 (+49.61%) and the highest is ¥25.65 (+53.50%).
Price Target: ¥25.33 (+51.59%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:600062 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 2 | 2 |
Financial Forecast
Revenue This Year
11.59B
from 11.00B
Increased by 5.37%
Revenue Next Year
12.18B
from 11.59B
Increased by 5.07%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 11.7B | ||
| Avg | 11.6B | ||
| Low | 11.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.1% | ||
| Avg | 5.4% | ||
| Low | 4.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |